Anti-lymphoma effect of naproxen and indomethacin in a patient with relapsed diffuse large B-cell lymphoma

Am J Hematol. 2001 Mar;66(3):220-3. doi: 10.1002/1096-8652(200103)66:3<220::aid-ajh1048>3.0.co;2-l.

Abstract

A 77-year-old man with relapsed non-Hodgkin's lymphoma, diffuse large B-cell type, was treated with naproxen, a nonsteroidal anti-inflammatory drug (NSAID), for paraneoplastic fever. A dramatic disappearance of not only the fever but also generalized lymphadenopathy was observed. Naproxen was continued, and he maintained remission for 10 months. When relapse of lymphoma occurred in spite of continuous naproxen administration, indomethacin, another type of NSAID, was tried. Surprisingly, rapid regression of lymphoma occurred again and was maintained for almost 1 year. These results indicate that NSAIDs are effective in some patients with non-Hodgkin's lymphoma.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
  • Fever
  • Humans
  • Indomethacin / administration & dosage
  • Indomethacin / therapeutic use*
  • Lymph Nodes / pathology
  • Lymphoma, B-Cell / drug therapy*
  • Lymphoma, B-Cell / pathology
  • Lymphoma, Large B-Cell, Diffuse / drug therapy*
  • Lymphoma, Large B-Cell, Diffuse / pathology
  • Male
  • Naproxen / administration & dosage
  • Naproxen / therapeutic use*
  • Recurrence
  • Remission Induction

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Naproxen
  • Indomethacin